Deep Genomics

About

Deep Genomics is at the forefront of revolutionizing drug development through the power of artificial intelligence. We utilize a sophisticated AI platform that efficiently analyzes RNA biology to uncover novel therapeutic targets. With a strong focus on RNA as a therapeutic modality, our proprietary AI, BigRNA, has been designed to facilitate breakthrough discoveries in drug development, tapping into the complexities and vastness of RNA data. Founded in 2014, our team comprises over 100 dedicated professionals with expertise across various domains, including AI, molecular biology, automation, and clinical development. The application of our technology promises to transform how genetic conditions are treated, as we work relentlessly to discover and develop RNA-targeted therapies that can potentially address a wide array of genetic diseases. As we continue to expand and evolve, our commitment to innovation and excellence in the biotechnology sector remains unwavering.